Market Introduction
Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. So, to stop addictions, there are several options available such as drug therapy, rehabilitation, which can stop addiction in a better way.
Market Overview and Dynamics
The Asia Pacific Addictions Therapeutics market is expected to reach US$ 1,781.09 million in 2027 from US$ 1,060.33 million in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020 to 2027. The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.
Key Market Segments
The Asia Pacific addictions therapeutics market, by drug type, is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest share of the market in 2019. However, the nicotine replacement products segment is anticipated to register the highest CAGR in the market during the forecast period.
By treatment center, the Asia Pacific addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. The outpatient treatment center segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
The Asia Pacific addictions therapeutics market, based on distribution channel, is segmented into hospital pharmacies, medical stores, and others. The hospital pharmacies segment held the largest share of the market in 2019. However, the medical stores segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the Asia Pacific addictions therapeutics market are India Brand Equity Foundation (IBEF); Centers for Disease Control and Prevention (CDC); Ministry of Health and Prevention (MoHAP) and National Health Service (NHS); among others.
Reasons to buy the report
ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET SEGMENTATION
By Treatment Type
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,060.33 Million |
| Market Size by 2027 | US$ 1,781.09 Million |
| CAGR (2020 - 2027) | 6.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Treatment Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Addictions Therapeutics Market is valued at US$ 1,060.33 Million in 2019, it is projected to reach US$ 1,781.09 Million by 2027.
As per our report Asia Pacific Addictions Therapeutics Market, the market size is valued at US$ 1,060.33 Million in 2019, projecting it to reach US$ 1,781.09 Million by 2027. This translates to a CAGR of approximately 6.8% during the forecast period.
The Asia Pacific Addictions Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Addictions Therapeutics Market report:
The Asia Pacific Addictions Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Addictions Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Addictions Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Addictions Therapeutics Market
